CLASS II Device recall · Reported 6 Jul 2022 · FDA Enforcement Report

TEG5000 Analyzer (07-022, 07-033) with TEG Analytical recalled

Haemonetics is recalling TEG5000 Analyzer (07-022, 07-033) with TEG Analytical, distributed nationwide in the US. The recall was initiated on 19 Apr 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesThis correction is applicable when TEG 5000 PlateletMapping (Item # 07-014, 07-015, 07-016) is performed on a TEG 5000 analyzer (Item # 07-022, 07-033) that is connected to TEG Manager Software which includes viewing of TEG 5000 results. Code Info: UDI-DI: (01)30812747018184 Software Version: TEGM 1.1 and later, TAS v4.2.3
Quantity recalled111

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1298-2022
FDA event ID
90358
Recalling firm
Haemonetics, Boston, MA
Classification
Class II
Status
Terminated
Recall initiated
19 Apr 2022
FDA classified
28 Jun 2022
Reported
6 Jul 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

19 Apr 2022Recall initiated by company
28 Jun 2022Classified by FDA+70 days
6 Jul 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

When the TEG 5000 Analyzer including TEG Analytical Software is used with PlateletMapping (ADP or AA) Assays and TEG Mangement Software, incorrect values of the PlateletMapping ADP or AA % Inhibition and % Aggretagion may be displayed on TEG Manager for the affected assays.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Product Name: TEG5000 Analyzer (07-022, 07-033) with TEG Analytical Software (07-030, 07-031) and TEG Platelet Mapping Assay - PlateletMapping ADP & AA (07-014), PlateletMapping ADP (07-015), PlateletMapping AA (07-016). Issue occurs when Platelet Mapping Assay results from a TEG 5000 analyzer are viewed using TEG Manager Software (versions 1.1-4.3.1)

Where it was distributed

US Nationwide.

Nationwide

Questions about this recall

Is TEG5000 Analyzer (07-022, 07-033) with TEG Analytical recalled?

Yes. Haemonetics recalled TEG5000 Analyzer (07-022, 07-033) with TEG Analytical on 19 Apr 2022. The recall is Class II and its status is Terminated. Recall number Z-1298-2022.

Why was it recalled?

When the TEG 5000 Analyzer including TEG Analytical Software is used with PlateletMapping (ADP or AA) Assays and TEG Mangement Software, incorrect values of the PlateletMapping ADP or AA % Inhibition and % Aggretagion may be displayed on TEG Manager for the affected assays.

Which lots are affected?

This correction is applicable when TEG 5000 PlateletMapping (Item # 07-014, 07-015, 07-016) is performed on a TEG 5000 analyzer (Item # 07-022, 07-033) that is connected to TEG Manager Software which includes viewing of TEG 5000 results. Code Info: UDI-DI: (01)30812747018184 Software Version: TEGM 1.1 and later, TAS v4.2.3

Where was it sold?

US Nationwide.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Haemonetics

All 31

Other Test Kits & Diagnostics recalls

All 2,656